Trinity Hospital | |
60 Easter Avenue, Weaverville, California 96093 | |
(530) 623-5541 | |
Not Available |
Name | Trinity Hospital |
---|---|
Type | Critical Access Hospital |
Location | 60 Easter Avenue, Weaverville, California |
Ownership | Government - Hospital District or Authority |
Emergency Services | Yes |
Medicare ID (CCN) | 051315 |
NPI Number | 1851767016 |
Organization Name | MOUNTAIN COMMUNITIES HEALTHCARE DISTRICT |
Doing Business As | TRINITY HOSPITAL |
Address | 60 Easter Ave, Weaverville, CA 96093 |
Hospital Type | General Acute Care Hospital - Critical Access |
Phone Number | 530-623-5541 |
News Archive
Biomedical scientists are working hard to create more pain-free methods of disease detection and treatment. A simple blood test is highly informative but arouses intense anxiety in many people. Now a new paper published in the journal Nature Biotechnology on November 25, 2019, reports on a new wearable sensor that can be successfully adapted to mass production, is flexible, and can be used to produce readouts of metabolites and nutrients in the blood based on a sweat analysis.
Pfizer today announced that it has entered into an agreement to acquire Idun Pharmaceuticals, a biopharmaceutical company focused on the discovery and development of therapies to control apoptosis, a process of cell death that occurs in a broad range of diseases.
Pharmaceutical and chemical giant Merck KGaA has been awarded Class A certification by Oliver Wight after dramatic improvements in service levels and a €15 million reduction in inventory, at its Darmstadt pharmaceutical production facility.
Questcor Pharmaceuticals, Inc. today announced that the commercial launch is now underway for H.P. Acthar® Gel (repository corticotropin injection) as monotherapy for the treatment of Infantile Spasms (IS) in infants and children under the age of two years. This new Acthar indication was approved by the U.S. Food and Drug Administration (FDA) on October 15, 2010.
› Verified 3 days ago
Able to receive lab results electronically | Not Available |
Able to track patients' lab results, tests, and referrals electronically between visits | Not Available |
News Archive
Biomedical scientists are working hard to create more pain-free methods of disease detection and treatment. A simple blood test is highly informative but arouses intense anxiety in many people. Now a new paper published in the journal Nature Biotechnology on November 25, 2019, reports on a new wearable sensor that can be successfully adapted to mass production, is flexible, and can be used to produce readouts of metabolites and nutrients in the blood based on a sweat analysis.
Pfizer today announced that it has entered into an agreement to acquire Idun Pharmaceuticals, a biopharmaceutical company focused on the discovery and development of therapies to control apoptosis, a process of cell death that occurs in a broad range of diseases.
Pharmaceutical and chemical giant Merck KGaA has been awarded Class A certification by Oliver Wight after dramatic improvements in service levels and a €15 million reduction in inventory, at its Darmstadt pharmaceutical production facility.
Questcor Pharmaceuticals, Inc. today announced that the commercial launch is now underway for H.P. Acthar® Gel (repository corticotropin injection) as monotherapy for the treatment of Infantile Spasms (IS) in infants and children under the age of two years. This new Acthar indication was approved by the U.S. Food and Drug Administration (FDA) on October 15, 2010.
› Verified 3 days ago
Trinity Hospital Critical Access Hospital Location: 60 Easter Avenue, Weaverville, California 96093 Phone: (530) 623-5541 |